feed,title,long_url,short_url
SeekingAlpha,Matinas BioPharma up 22% on phase 2 data on meningitis candidate,https://seekingalpha.com/news/3739141,
SeekingAlpha,What's Wrong With Gold? Absolutely Nothing,https://seekingalpha.com/article/4454895,
